| M0 | AML, APL (M1-M3) | AMML (M4) | AMoL (M5) | AEL (M6) | AMKL (M7) | ALL | ||
|---|---|---|---|---|---|---|---|---|
| Myeloperoxidase | - | + | + | - | - | - | - | |
| Nonspecific esterases | ||||||||
| Chloracetate | - | + | + | ± | - | - | - | |
| Alpha-naphthol acetate | - | - | + b | + b | - | ± b | - | |
| Sudan Black B | - | + | + | - | - | - | - | |
| PAS | - | - | ± | ± | + | - | + | |
AEL = acute erythroid leukemia; ALL = acute lymphoblastic leukemia; AML = acute myeloid leukemia; AMKL = acute megakaryocytic leukemia; AMML = acute myelomonocytic leukemia; AMoL = acute monocytic leukemia; APL = acute promyelocytic leukemia; PAS = periodic acid-Schiff.
aRefer to the French-American-British (FAB) Classification for Childhood Acute Myeloid Leukemia section of this summary for more information about the morphologic-histochemical classification system for AML.
bThese reactions are inhibited by fluoride.
From: Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.